Back to Search Start Over

Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer.

Authors :
Chen, Chengcong
Feng, Yan Summer
Wang, Ziyi
Gupta, Manish
Xu, Xu Steven
Yan, Xiaoyu
Source :
European Journal of Cancer. Aug2024, Vol. 207, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

We aim to compare the prognostic value of organ-specific dynamics with the sum of the longest diameter (SLD) dynamics in patients with metastatic colorectal cancer (mCRC). All datasets are accessible in Project Data Sphere, an open-access platform. The tumor growth inhibition models developed based on organ-level SLD and SLD were used to estimate the organ-specific tumor growth rates (KGs) and SLD KG. The early tumor shrinkage (ETS) from baseline to the first measurement after treatment was also evaluated. The relationship between organ-specific dynamics, SLD dynamics, and survival outcomes (overall survival, OS; progression-free survival, PFS) was quantified using Kaplan-Meier analysis and Cox regression. This study included 3687 patients from 6 phase III mCRC trials. The liver emerged as the most frequent metastatic site (2901, 78.7 %), with variable KGs across different organs in individual patients (liver 0.0243 > lung 0.0202 > lymph node 0.0127 > other 0.0118 [week−1]). Notably, the dynamics for different organs did not equally contribute to predicting survival outcomes. In liver metastasis cases, liver KG proved to be a superior prognostic indicator for OS and surpasses the predictive performance of SLD, (C-index, liver KG 0.610 vs SLD KG 0.606). A similar result can be found for PFS. Moreover, liver ETS also outperforms SLD ETS in predicting survival. Cox regression analysis confirmed liver KG is the most significant variable in survival prediction. In mCRC patients with liver metastasis, liver dynamics is the primary prognostic indicator for both PFS and OS. In future drug development for mCRC, greater emphasis should be directed towards understanding the dynamics of liver metastasis development. • Tumor lesions in the liver have the most significant impact on survival. • Liver KG surpasses the predictive performance of the SLD KG. • Organ-level TGI model may be a more suitable option for mCRC clinical trials. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09598049
Volume :
207
Database :
Academic Search Index
Journal :
European Journal of Cancer
Publication Type :
Academic Journal
Accession number :
178357293
Full Text :
https://doi.org/10.1016/j.ejca.2024.114147